1. Home
  2. CREX vs CELU Comparison

CREX vs CELU Comparison

Compare CREX & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

N/A

Current Price

$3.68

Market Cap

36.8M

Sector

Technology

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.22

Market Cap

36.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CREX
CELU
Founded
N/A
2016
Country
United States
United States
Employees
N/A
123
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
36.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CREX
CELU
Price
$3.68
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
26.9K
101.9K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
N/A
EPS
N/A
N/A
Revenue
$18,437,000.00
N/A
Revenue This Year
$11.51
N/A
Revenue Next Year
$83.66
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$1.28
$1.01
52 Week High
$4.00
$4.35

Technical Indicators

Market Signals
Indicator
CREX
CELU
Relative Strength Index (RSI) 59.04 50.47
Support Level $3.01 $1.21
Resistance Level $3.70 $1.38
Average True Range (ATR) 0.16 0.10
MACD -0.01 0.00
Stochastic Oscillator 61.25 34.62

Price Performance

Historical Comparison
CREX
CELU

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: